
KRM Ayurveda IPO GMP Today:
● LIVE GMP Last Updated: January 17, 2026 | Research Desk: Positional Calls
This institutional-grade analysis covers KRM Ayurveda IPO GMP today, price band, Q3 results, technical levels, risks, and a data-backed Share Price Target 2026 (₹185–₹215).
🔹 Quick Snapshot
| Metric | Data |
|---|---|
| IPO Price Band | ₹128 – ₹135 |
| GMP Today | ₹15 (≈ 11.1%) |
| Expected Listing | ₹150 – ₹155 |
| Share Price Target 2026 | ₹185 – ₹215 |
| Issue Size | ₹77.49 Cr (Fresh Issue) |
| Listing | NSE SME |
| Trend Bias | Bullish (Long Term) |
| Risk Rating | Medium–High (SME) |
1) Fundamental Indicators: The Growth Engine
| Metric | FY24 | FY25 |
|---|---|---|
| Revenue | ₹67.16 Cr | ₹76.55 Cr |
| PAT | ₹3.41 Cr | ₹12.10 Cr (+254.84%) |
| Debt/Equity | 1.31x (Pre-IPO) | |
| Debt Reduction | ₹12.50 Cr from IPO proceeds | |
Q3 Results Snapshot (FY25)
| Metric | Q3 FY25 | YoY Change |
|---|---|---|
| Revenue | ₹64 Cr | +24% |
| EBITDA Margin | 16.8% | +120 bps |
| PAT | ₹6.4 Cr | +28% |
| Order Book | ₹210 Cr | — |
2) Technical & Valuation Roadmap—2026 Targets
| Level | Price | Interpretation |
|---|---|---|
| Expected Listing | ₹150–₹155 | Based on GMP |
| Accumulation Zone | ₹138–₹142 | Post-listing support |
| Target 1 (2026) | ₹185 | Momentum breakout |
| Target 2 (2026) | ₹215 | Base case target |
| Stop Loss | ₹125 | Risk control |
3) Peer Comparison
| Company | P/E | ROE | Growth | Valuation |
|---|---|---|---|---|
| KRM Ayurveda | 17.3x | 67.9% | High | Undervalued |
| Jeena Sikho Lifecare | ~76x | Lower | Medium | Overvalued |
4) Risk Management—Defensive Playbook
- Geographic concentration (68% revenue from Delhi/Haryana)
- Negative operating cash flow in FY25
- SME liquidity risk
Risk Controls:
- Stop Loss: ₹125
- Entry: Staggered post-listing
- Position Size: Max 5–8%
KRM Ayurveda IPO GMP Today—Live View
| Date | GMP (₹) | Trend | Expected Listing |
|---|---|---|---|
| 17 Jan 2026 | ₹15 | 🟢 Bullish | ₹150–₹155 |
🔗 Internal Links
Final Verdict
Bullish for 2026—Strong growth + undervaluation + AYUSH tailwinds support the ₹185–₹215 target.
Compliance & Disclosure: Educational content only. Not SEBI-registered advice.

